Market Assessment, Dry and Wet Age Related Macular Degeneration TreatmentTrends US 2014 Report

TreatmentTrends: Dry/Wet Age-Related Macular Degeneration (US) is an annual syndicated report series that offers a snapshot of dry and wet age-related macular degeneration (AMD) market dynamics and competitive landscape through comprehensive primary research with U.S. retinal specialists and general ophthalmologists. The report covers the current use of intravitreal injections, in particular anti-VEGF agents, for the treatment of AMD, as well as attitudes and perceptions toward these products, advantages and disadvantages, ideal patient types, barriers to growth, promotional activity, and anticipated use. In addition, respondents are queried about their awareness of and inter-est in products in development.

Back to all Market Assessment reports

Contact us

Investors

Careers

Login

Dry and Wet Age-Related Macular Degeneration | TreatmentTrends | US | 2014

Related Market Assessment Reports

Vitiligo – Executive Insights – Executive Insights (US)

Dry Eye – Access & Reimbursement – Detailed, Expanded Analysis (US)

Obesity/Overweight – Unmet Need – Detailed, Expanded Analysis (US/EU)

Myasthenia Gravis – Current Treatment – Detailed, Expanded Analysis (US)

Non-Small-Cell Lung Cancer – Current Treatment – Detailed, Expanded Analysis (US)